Page last updated: 2024-10-23

buformin and Cardiac Failure

buformin has been researched along with Cardiac Failure in 2 studies

Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, S1
Takeuchi, K1
Ito, S1
Buess, HJ1
Mihatsch, MJ1
Wunderlich, P1
Berger, W1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Study of PPAR-Gamma Agonist-Rosiglitazone for Determining Cardiac Adverse Effects in Type 2 Diabetic Patients[NCT00300911]Phase 445 participants Interventional2005-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for buformin and Cardiac Failure

ArticleYear
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

    Topics: Aged; Atrial Natriuretic Factor; Body Mass Index; Buformin; Diabetes Mellitus, Type 2; Female; Glyca

2003

Other Studies

1 other study available for buformin and Cardiac Failure

ArticleYear
[Lactic acidosis in diabetes mellitus (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1976, Apr-06, Volume: 65, Issue:14

    Topics: Acidosis; Aged; Alcoholism; Buformin; Diabetes Complications; Female; Heart Failure; Humans; Hyperte

1976